Arkolith/Insider Trading/AADI/Form 4

Desai Neil

Executive Chairman, Director, 10% OwnerAadi Bioscience, Inc. (AADI) · full profile →Form 4 · filed Apr 5, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$218K
Net Open-Market Flow
-$218K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 5, 2023Sell(S)7K$7.24$53K1.9M
Apr 4, 2023Sell(S)13K$7.30$94K1.9M
Apr 3, 2023Sell(S)10K$7.45$71K1.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-023483) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML